PzF Antithrombotic Coating Services for Blood-Contacting Medical Devices

What is PzF coating?

PzF is a thin-film polymer coating technology used to modify the surface of medical devices, including vascular and other blood-contacting devices. Alta Biomed evaluates PzF coating feasibility based on the device material, geometry, intended use, blood-contacting surfaces, and development goals.

Is PzF an antithrombotic coating?

PzF may be evaluated as an antithrombotic surface modification for blood-contacting medical devices where thrombus formation, fibrin deposition, platelet interaction, or hemocompatibility are important development considerations. Device-specific testing is recommended to evaluate coated vs. uncoated performance.

What types of medical devices can be evaluated for PzF coating?

Alta Biomed supports PzF coating feasibility for vascular and blood-contacting devices such as stents, covered stents, vascular grafts, ePTFE grafts, catheters, blood filters, nitinol frames, PET/polyester devices, and other implantable or blood-contacting components.

What materials can be coated with PzF?

PzF coating feasibility may be evaluated on materials such as nitinol, stainless steel, cobalt chromium, PET/polyester, ePTFE, PTFE, Pebax, polyurethane, TPU, PCU, silicone, and other medical device polymers or metals. Material compatibility should be evaluated using representative samples or finished devices.

Can PzF be applied to complex device geometries?

PzF may be evaluated on complex devices, including small features, porous materials, lumens, struts, frames, grafts, filters, and catheter-based components. Coating feasibility depends on surface access, material compatibility, wetting, coating uniformity, drying behavior, and inspection requirements.

Is surface preparation required before PzF coating?

Surface preparation is often an important part of coating development. Depending on the material and device, surface preparation may include cleaning, plasma treatment, adhesion promotion, or other steps designed to improve coating coverage and attachment.

How do you determine whether a device is suitable for PzF coating?

Alta typically begins with a device and material review, followed by coating feasibility testing on representative coupons, components, prototypes, or finished devices. The evaluation may include coating coverage, visual inspection, surface characterization, coating integrity, simulated use, and testing of coated vs. uncoated samples.

How is PzF coating performance evaluated?

PzF-coated devices may be evaluated using a combination of visual inspection, surface characterization, coating integrity testing, simulated use evaluation, acute particulate testing, and hemocompatibility testing. The test strategy should be based on the device type, intended use, blood contact duration, and development objective.

Can Alta compare coated and uncoated devices?

Yes. Coated vs. uncoated comparison testing is often useful during coating feasibility and development. Alta can support comparisons using coating inspection, simulated use evaluation, acute particulate testing, and dynamic human blood loop testing when appropriate.

Does Alta perform hemocompatibility testing?

Yes. Alta Biomed provides dynamic human blood loop testing support for blood-contacting medical devices. This testing can be used to compare coated and uncoated devices and evaluate thrombus-related or blood-material interaction endpoints under controlled conditions.

Can Alta support coating integrity and particulate testing?

Yes. Alta supports coating integrity inspection and acute particulate testing for coated medical devices. Testing may include simulated use, microscopy, particulate assessment, and comparison of coated vs. uncoated or process-iteration samples.

What is the difference between antithrombotic, antithrombogenic, thromboresistant, and non-thrombogenic?

These terms are often used interchangeably to describe surfaces intended to reduce unwanted blood-material interactions that may contribute to thrombus formation. In practice, the preferred term may depend on the device type, test method, regulatory context, and specific endpoint being evaluated.